Ledger.Open graph →
SEC Form D · filed July 31, 2019

Solid Biosciences Inc

Offering
$60.0M
Sold
$60.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Cambridge, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (29)

Martha Osier · Saint-Pierre, O4ExecWayne M. Rehberger · BALTIMORE, MDDirectorAlvaro Amorrortu · Cambridge, MAExecFlorent De Boissieu · Saint-Pierre, O4DirectorLuke Walker · WILMINGTON, DEDirectorSamuel B. Cates · Boston, MAExec · DirectorMartin A. Freed · Cambridge, MADirectorLisa Audet · Greenwich, CTExecStephane Bacquaert · Saint-Pierre, O4DirectorJorge A. Quiroz · Cambridge, MAExecTom Werthan · BALTIMORE, MDDirectorLorenzo Delzoppo · WILMINGTON, DEDirectorAlexis Caude · Saint-Pierre, O4ExecPavel Livshiz · New York, NYDirectorRajeev A. Shah · Cambridge, MADirectorNnennia Ejebe · Saint-Pierre, O4ExecCharles Boatin · Saint-Pierre, O4DirectorJared Kehe · Allston, MAExecChris M. Rosenthal · BALTIMORE, MDDirectorKeith M. Jackson · BALTIMORE, MDDirectorAndrey A. Zarur · Cambridge, MADirectorAdam Mullinax · Boston, MAExecAntoine Delaporte · Saint-Pierre, O4ExecDavid Shainok · New York, NYDirectorRon Efroni Rotman · New York, NYDirectorJeffrey B. Beir · Boston, MAExecChristophe Scalbert · Saint-Pierre, O4Exec · DirectorMark Goode · WILMINGTON, DEDirectorAndrew Gavin · BALTIMORE, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗